Local Bounti Q1 2026 Earnings EPS Beats Estimates but Stock Declines TRMB Q1 2026 Earnings EPS Beats Estimates by 794 as Stock Edges Higher CDLX Q1 2026 Earnings Strong EPS Beat Driven by Cost Discipline Revenue Remains Under Wraps Day One Biopharmaceuticals Q4 2025 Earnings EPS Miss Amid Continued RD Investment DINO Q1 2026 Earnings Stunning EPS Surge Defies Expectations Eikon Therapeutics Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline